Pharmerit_WPadmin

/Pharmerit_WPadmin

About Pharmerit_WPadmin

This author has not yet filled in any details.
So far Pharmerit_WPadmin has created 194 blog entries.

Extrapolation in Survival Analysis: What? Why? How? Where next?

Survival analysis plays a key role in many cost-effectiveness analyses, particularly those involving products in oncology. During this webinar, presenters will provide an introduction to survival analysis, demonstrate why extrapolation is important, and offer an overview of current methods and [...]

2018-10-29T13:23:44+00:00 October 29th, 2018|

Treatment patterns and healthcare resource utilization among patients with hereditary angioedema in the United States

Treatment patterns and healthcare resource utilization among patients with hereditary angioedema in the United States Background Real-world data on usage and associated outcomes with hereditary angioedema (HAE)-specific medications introduced to the United States (US) market since [...]

2018-10-26T06:34:16+00:00 October 26th, 2018|

Cost-Effectiveness Analysis of Voriconazole, Fluconazole, and Amphotericin B for Invasive Fungal Infections Following Allogeneic Hematopoietic Stem Cell Transplantation in Mexico

Cost-Effectiveness Analysis of Voriconazole, Fluconazole, and Amphotericin B for Invasive Fungal Infections Following Allogeneic Hematopoietic Stem Cell Transplantation in Mexico Background Patients receiving allogeneic hematopoietic stem cell transplantation (alloHSCT) are [...]

2018-09-13T14:57:16+00:00 September 11th, 2018|

Cost analysis for different sequential treatment regimens for metastatic renal cell carcinoma in China

Cost Analysis for Different Sequential Treatment Regimens for Metastatic Renal Cell Carcinoma in China Purpose Targeted therapies including sunitinib, sorafenib, axitinib, and everolimus have recently become the mainstay for the [...]

2018-08-30T11:26:39+00:00 August 30th, 2018|

Cardiovascular Hazards of Insufficient Treatment of Depression Among Patients with Known Cardiovascular Disease: A Propensity Score Adjusted Analysis

Cardiovascular Hazards of Insufficient Treatment of Depression Among Patients with Known Cardiovascular Disease: A Propensity Score Adjusted Analysis Aims The association between depression care adequacy and the risk of subsequent [...]

2018-07-24T10:55:36+00:00 July 20th, 2018|

Development of a Comprehensive Dataset of Hepatitis C Patients and Examination of Disease Epidemiology in the United States, 2013-2016

Development of a Comprehensive Dataset of Hepatitis C Patients and Examination of Disease Epidemiology in the United States, 2013-2016 Introduction Chronic infection with hepatitis C virus (HCV) is a leading [...]

2018-07-16T08:51:58+00:00 July 16th, 2018|

Quality-Adjusted Survival With nab-Paclitaxel Versus Standard Paclitaxel in Metastatic Breast Cancer: A Q-TWiST Analysis

Quality-Adjusted Survival With nab-Paclitaxel Versus Standard Paclitaxel in Metastatic Breast Cancer: A Q-TWiST Analysis Background In this analysis we compared quality-adjusted survival outcomes between nab-paclitaxel (nab-P) and standard paclitaxel (Pac) [...]

2018-06-29T06:45:40+00:00 June 29th, 2018|

Quality-adjusted Outcomes Stratified by Response in Patients With Advanced Non-Small-cell Lung Cancer Receiving First-line nab-Paclitaxel/Carboplatin or Paclitaxel/Carboplatin

Quality-adjusted Outcomes Stratified by Response in Patients With Advanced Non-Small-cell Lung Cancer Receiving First-line nab-Paclitaxel/Carboplatin or Paclitaxel/Carboplatin Background First-line nab-paclitaxel/carboplatin was associated with a significantly improved overall response rate (primary [...]

2018-06-29T06:15:19+00:00 June 29th, 2018|